Results 161 to 170 of about 2,272,470 (209)
Some of the next articles are maybe not open access.
Copper on Intrauterine Devices Stimulates Leukocyte Exudation
Science, 1972Metallic copper in the uterine or abdominal cavities of rats or monkeys stimulates an impressive local exudation of polymorphonuclear leukocytes. This cellular response to copper persists for at least 7 months, without significant local tissue damage or detectable systemic effects on the test animal. This finding provides a possible explanation for the
A, Cuadros, J G, Hirsch
openaire +2 more sources
URTICARIA SECONDARY TO A COPPER INTRAUTERINE DEVICE
International Journal of Dermatology, 1976ABSTRACT: A 24‐year‐old woman developed an acute urticarial reaction secondary to a copper intrauterine contraceptive device. Allergy to copper was proven by scratch tests. The condition cleared with removal of the IUD.
openaire +2 more sources
COPPER INTRAUTERINE CONTRACEPTIVE DEVICES IN ADOLESCENT NULLIPARAE
BJOG: An International Journal of Obstetrics & Gynaecology, 1978SummaryCopper intrauterine contraceptive devices (IUCDs) were used in 243 young nulligravidae attending a gynaecological clinic for schoolgirls in Uppsala between March 1973 and June 1975; 226 of these girls (93 per cent) were seen again during December 1975 making a total of 3138 months of observation.
E, Weiner, A A, Berg, I, Johansson
openaire +2 more sources
Reactive molecules and microorganisms and copper intrauterine devices
International Journal of Gynecology & Obstetrics, 2005Copper in the intrauterine device (IUD) has been shown to have bactericidal activity in addition to enhancing contraceptive activity. However the exact mechanism of antimicrobial action of copper IUD is not known. The increase in the number of polymorphonuclear leukocytes in the endometrium following IUD insertion has been documented.
M, Navada, I, Gupta, V, Dhawan
openaire +2 more sources
Copper release from copper-T intrauterine devices
Contraception, 1976Abstract In this investigation of the copper loss in utero from the Copper-T, the release rate was estimated by iodometric titration and the corrosion was microscopically examined in ground plastic casts. The release rate was determined in 28 preweighed Copper-Ts with a surface area of 100–400 mm 2 during the first month, and in 60 Copper-T-200s (TCu-
openaire +2 more sources
Copper intrauterine contraceptive device and pregnancy rate
Advances in Contraception, 1994Between August 1983 and August 1992, 1995 women aged 20-43 years were fitted with 2736 copper intrauterine contraceptive devices (MLCu250, MLCu375, Nova-T, Gravigard, Anticon). Insertion of the IUD was performed during menstruation by a skilled team of gynecologists. The women were instructed to self-check the IUD tail after each menstrual period.
J, Bontis +3 more
openaire +2 more sources
2010
The Intrauterine Device (IUD) is the most commonly used form of reversible contraception throughout the world [1], and in some countries it accounts for 40% of the contraception used by women [2]. In the United States (US), current use is 0.8% of the contraceptive population [3].
openaire +1 more source
The Intrauterine Device (IUD) is the most commonly used form of reversible contraception throughout the world [1], and in some countries it accounts for 40% of the contraception used by women [2]. In the United States (US), current use is 0.8% of the contraceptive population [3].
openaire +1 more source
Menstrual blood loss with copper intrauterine devices
Contraception, 1974Abstract Menstrual blood loss was estimated quantitatively by Halberg & Nilson method for 336 women: 145 normal controls (240 cycles); 91 fitted with Cu-devices (349 collected cycles); 50 fitted with Lippes loops (224 cycles) and 50 on combined steroid contraceptive therapy (236 cycles).
F, Hefnawi, H, Askalani, K, Zaki
openaire +2 more sources
Clinical Experience with the Copper 7 Intrauterine Device
Fertility and Sterility, 1978This paper reports further observations on our previous study of 203 Copper 7 intrauterine insertions performed in 199 women. There have now been accumulated 3799 woman-months of use. At least a 2-year period of observation has been attained from first insertion until these data were analyzed.
W A, Nebel, J L, Currie, R E, Lassiter
openaire +2 more sources
Copper intrauterine devices in the management of secondary amenorrhea
International Journal of Gynecology & Obstetrics, 2006Secondary amenorrhea has always been a challenge for the gynecologist. The incidence is reported to be between 1.4% and 3% in the general population [1,2], and its causes can be hypothalamic (62%), pituitary (15%), ovarian (12%), or anatomical (7%). Intrauterine devices have been used to treat Asherman syndrome. Lately, copper intrauterine devices have
N, Dubey, S S, Trivedi, S, Pasrija
openaire +2 more sources